Sustained Immunogenic and Clinical Effects of Low-Dose Interleukin-2 Therapy with an Intermittent Maintenance Method for Refractory Chronic Graft-Versus-Host Disease: Results of Phase1/2a LDIL2-01 Study

被引：0

作者：

Meguri, Yusuke ^{[1
]}

Ohashi, Kazuteru ^{[2
]}

Inamoto, Yoshihiro ^{[3
]}

Iyama, Satoshi ^{[4
]}

Ohwada, Chikako ^{[5
]}

Murata, Makoto ^{[6
]}

Satake, Atsushi ^{[7
]}

Mori, Yasuo ^{[8
]}

Nakase, Koichi ^{[9
]}

Yoshida, Chikamasa ^{[10
]}

Doki, Noriko ^{[2
]}

Najima, Yuho ^{[2
]}

Nishida, Tetsuya ^{[6
]}

Maeda, Yoshinobu ^{[1
]}

Matsuoka, Ken-ichi ^{[1
]}

机构：

[1] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan

[2] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Hematol Div, Tokyo, Japan

[3] Natl Canc Ctr, Dept Hematopoiet Stem Cell Transplantat, Tokyo, Japan

[4] Sapporo Med Univ Hosp, Dept Hematol, Sapporo, Hokkaido, Japan

[5] Chiba Univ Hosp, Dept Hematol, Chiba, Japan

[6] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi, Japan

[7] Kansai Med Univ, Dept Internal Med 1, Osaka, Japan

[8] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka, Japan

[9] Ehime Prefectural Cent Hosp, Div Hematol, Matsuyama, Ehime, Japan

[10] Natl Hosp Org Minami Okayama Med Ctr, Div Hematol, Okayama, Japan

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

256

引用

页码：S175 / S175

页数：1

共 50 条

[31] A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
Yngvar Fløisand
Mark A. Schroeder
Patrice Chevallier
Dominik Selleslag
Steven Devine
Anne S. Renteria
Mohamad Mohty
Ibrahim Yakoub-Agha
Chunlin Chen
Andrejus Parfionovas
Syed Quadri
Johan Jansson
Mona Akbari
Yi-Bin Chen
Bone Marrow Transplantation, 2021, 56 : 2477 - 2488
[32] T Follicular Regulatory (TFR) Cell Deficiency during Chronic Graft-Versus-Host Disease Is Improved By Low-Dose IL-2 Therapy
Forcade, Edouard
Kamihara, Yusuke
Kim, Haesook T.
Douchet, Isabelle
Koreth, John
Hirakawa, Masahiro
Cutler, Corey
Nikiforow, Sarah
Ho, Vincent T.
Armand, Philippe
Alyea, Edwin, III
Blanco, Patrick
Blazar, Bruce
Antin, Joseph H.
Soiffer, Robert J.
Ritz, Jerome
BLOOD, 2017, 130
[33] Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host disease
Salhotra, Amandeep
Talley, Min
Wu, Xiwei
Tsai, Weimin
Mokhtari, Sally
Qin, Hanjun
Al-Malki, Monzr M.
Aldoss, Ibrahim
Modi, Badri
Koller, Paul
Kopp, Erin
Smith, Eileen
Pawlowska, Anna
Nakamura, Ryotaro
BONE MARROW TRANSPLANTATION, 2022, 57 (06) : 1045 - 1047
[34] Clinical and immunologic responses to extracorporeal photopheresis and low-dose IL-2 in patients with steroid refractory chronic graft-versus host disease
Amandeep Salhotra
Min Talley
Xiwei Wu
Weimin Tsai
Sally Mokhtari
Hanjun Qin
Monzr M. Al-Malki
Ibrahim Aldoss
Badri Modi
Paul Koller
Erin Kopp
Eileen Smith
Anna Pawlowska
Ryotaro Nakamura
Bone Marrow Transplantation, 2022, 57 : 1045 - 1047
[35] Low-Dose Interleukin-2 Restores Human Regulatory T Cell Function, in Vitro, As a Potential in the Handle of Graft Versus Host Disease (GvHD)
Chiou, Tzeon-Jye
Lin, Hsiu-Hsia
Wu, Wei-Hao
Jian, Jhih-Yun
Chu, Sin-Tak
Tzeng, Woan-Fang
BLOOD, 2017, 130
[36] Extra-Corporeal Photopheresis Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease: Efficacy, Safety and Immune Correlates
Koreth, John
Kim, Haesook T.
Belizaire, Roger
Poryanda, Samuel J.
Reynolds, Carol
Whangbo, Jennifer
Nikiforow, Sarah
Alyea, Edwin, III
Armand, Philippe
Cutler, Corey
Ho, Vincent T.
Blazar, Bruce
Antin, Joseph H.
Ritz, Jerome
Soiffer, Robert J.
BLOOD, 2017, 130
[37] Individual Patient Dose-Escalated Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease in Children and Adults: Safety, Efficacy and Immune Correlates
Whangbo, Jennifer
Kim, Haesook T.
Stewart, Jeremy
Leonard, Lauren
Poryanda, Samuel
Silverstein, Sophie
Kim, Soomin
Reynolds, Carol
Fields, Marie
Verrill, Kelly
Lee, Michelle
Margossian, Steven
Duncan, Chrstine
Lehmann, Leslie E.
Nikiforow, Sarah
Alyea, Edwin P.
Armand, Philippe
Cutler, Corey
Ho, Vincent T.
Blazar, Bruce R.
Antin, Joseph H.
Ritz, Jerome
Soiffer, Robert J.
Koreth, John
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
[38] Individual Patient Dose-Escalated Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-Vs.-Host Disease in Children and Adults: Safety, Efficacy and Immune Correlates
Whangbo, Jennifer
Kim, Haesook T.
Stewart, Jeremy
Leonard, Lauren
Kim, Soomin
Reynolds, Carol
Chammas, Marie
Verrill, Kelly
Lee, Michelle A.
Margossian, Steven P.
Duncan, Christine
Lehmann, Leslie E.
Nikiforow, Sarah
Alyea, Edwin
Armand, Philippe
Cutler, Corey
Ho, Vincent T.
Blazar, Bruce
Antin, Joseph H.
Ritz, Jerome
Soiffer, Robert J.
Koreth, John
BLOOD, 2017, 130
[39] Prophylactic and Therapeutic Effects of Interleukin-2 (IL-2)/Anti-IL-2 Complexes in Systemic Lupus Erythematosus-Like Chronic Graft-Versus-Host Disease
Heiler, Stefan
Loetscher, Jonas
Kreuzaler, Matthias
Rolink, Johanna
Rolink, Antonius
FRONTIERS IN IMMUNOLOGY, 2018, 9
[40] Rituximab and total nodal irradiation in the treatment of extensive chronic graft-versus-host disease: interim results of a phase 2 study
He, S.
Wirth, A.
Moore, J.
Szer, J.
Roberts, A.
Peppin, J.
Ritchie, D.
Grigg, A.
BONE MARROW TRANSPLANTATION, 2012, 47 : S409 - S410

← 1 2 3 4 5 →